Zi Cao (Lithospermum / Arnebia) Pharmacology — Shikonin, Acetylshikonin, and the Naphthoquinone Root That Stains Burn Oils Burgundy Red

Open a jar of properly made Zicao Gao — the purple-root ointment that sits on a back shelf in every Chinese pharmacy from Shanghai to Singapore — and the first thing you notice is the colour. It is not red. It is not purple. It is the deep, almost-black burgundy of a Pinot Noir poured into a white porcelain bowl, and when you smear it on gauze it leaves a wine-coloured shadow that takes three days to wash out of cotton. The same colour soaks through the wax of Hua Gang Seishū’s 18th-century Shiun-Kō (紫雲膏) in Japan, through Taiwan apothecary nappy-rash oils, and through hospital-compounded burns dressings in Beijing and Chengdu. All of it comes from one chemical family: the naphthoquinone pigments of the Boraginaceae roots collectively called Zi Cao — the “purple grass.”

Zi Cao is one of the very few materia medica that is high-status in every East Asian pharmacopoeia at once. Shennong Bencao Jing lists it as a middle-grade herb for “evil qi in the heart and abdomen, the five jaundices.” Bencao Gangmu records it as a remedy for “macular eruptions, smallpox toxin, blood activation and cooling.” Japanese kanpo doctors still teach Shiun-Kō as the first dermatological formula a junior practitioner learns to compound by hand. And modern Chinese burns units in tertiary hospitals carry a hospital-compounded “Zi Cao You” (紫草油) on their crash trolleys for partial-thickness burn dressings.

This article takes apart the root: its botanical sources, the naphthoquinone chemistry that makes it pharmacologically interesting, the mechanisms that earn it a place in 21st-century wound-healing literature, and — equally important — why it is almost exclusively used externally, even though the Shennong Bencao Jing placed it in the internal-medicine cabinet.

Botanical and Pharmacopoeial Identity — Why “Zi Cao” Is a Drug Name, Not a Species

“Zi Cao” is a drug name, not a taxon. Over two thousand years of use it has been pulled from at least three different Boraginaceae genera, and the modern pharmacopoeias have quietly re-pointed the name in the last two decades. This matters intensely for safety and for sourcing.

Soft Zi Cao — Lithospermum erythrorhizon (de-listed in 2005)

Lithospermum erythrorhizon Sieb. et Zucc. — known as soft Zi Cao (软紫草), eastern Zi Cao, or Yunnan Zi Cao — is the historical mainland-Chinese, Japanese (as shikon, 紫根), and Korean (자초) source. Roots are soft, blackish-purple, easily peeled.

It is also the source that contemporary Chinese regulators have walked away from. The 2005 and 2020 editions of the Chinese Pharmacopoeia removed L. erythrorhizon from the official source list for Zi Cao because of measurable levels of pyrrolizidine alkaloids (PAs) — a class of compounds with documented hepatotoxic and hepatic-veno-occlusive-disease risk when ingested. L. erythrorhizon is still used in Japanese kanpo (where the regulatory rationale is different and the use is overwhelmingly topical) and in Korean herbal medicine, but in PRC manufacturing it is now a non-pharmacopoeia species.

Hard Zi Cao — Arnebia euchroma and A. guttata (current official source)

Arnebia euchroma (Royle) Johnst., known as hard Zi Cao (硬紫草), Xinjiang Zi Cao, or Tibetan Zi Cao, has hard, deep red-purple, layered-cross-section roots harvested mainly from Xinjiang, Tibet, and Gansu. Arnebia guttata Bunge (内蒙紫草, Inner Mongolian Zi Cao) is added as a parallel source.

The 2020 Chinese Pharmacopoeia is unambiguous: the legal source of “Zi Cao” in PRC-manufactured drugs is Arnebia euchroma or Arnebia guttata — both Boraginaceae, both naphthoquinone-rich, both with much lower PA loads than Lithospermum erythrorhizon.

The practical consequence: if you read a research paper from a Japanese kanpo lab, a Korean dermatology study, and a Chinese hospital compounding monograph that all use the name “Zicao,” you are reading about three different — though chemically overlapping — botanical raw materials. The shikonin chemistry transfers cleanly; the PA toxicology and the trace constituents do not.

The Pigment Chemistry — Why It Is the Colour of Wine

The active fraction of every Zi Cao species is the lipophilic naphthoquinone pigment complex in the root cortex. To date, roughly 28 naphthoquinones have been isolated from the genus. They fall into two stereochemical mirror families:

• Shikonin and its esters — the R-enantiomer family, dominant in Lithospermum erythrorhizon. Members include shikonin, acetylshikonin, β,β-dimethylacrylshikonin, isobutylshikonin, and β-hydroxyisovalerylshikonin (β-HIVS).
• Alkannin and its esters — the S-enantiomer family, dominant in Alkanna tinctoria (a European Boraginaceae) and present alongside shikonin in Arnebia euchroma. Members include alkannin and β,β-dimethylacryl-alkannin (DMA / arnebin-1).

Both enantiomers carry the same naphthoquinone backbone and behave very similarly in pharmacology assays. The colour — deep red in oil, deep purple in alcohol, blue-violet in alkali — comes from the naphthoquinone chromophore and shifts predictably with solvent pH. Old apothecaries used this as an authentication test: a true Zi Cao infusion turns purple-blue in a drop of dilute ammonia and back to red in vinegar.

Crucially, these pigments are fat-soluble, not water-soluble. Boiling Zi Cao in water gives a pale brown decoction with most of the actives left behind in the marc. This is the molecular reason that Zi Cao has been a topical-oil herb for two thousand years rather than a tea: classical practitioners discovered empirically that they needed sesame oil, beeswax, or a lard base to extract the colour and the activity. Modern pharmacognosy calls this “lipophilic-only extraction” and it has been on the front page of every Zi Cao processing monograph since.

The traditional Zicao Gao preparation makes the chemistry visible:

Soak Zi Cao (30 g) + Dang Gui (15 g) + Chuan Jiao (3 g) in 300 mL sesame oil for 24 h, gently heat to a boil, add Chuan Shan Jia (9 g), strain, then incorporate 60 g beeswax.

The 24-hour cold soak is not folklore — it is the period needed for the naphthoquinone pigments to partition into the sesame triglycerides before heat is applied. Heat too early and you scorch the pigments; cold-only and you under-extract. The result is the burgundy-red wax ointment that anyone who has worked in an East Asian dispensary will recognise on sight.

Pharmacology — What Shikonin Actually Does in Skin

Modern molecular pharmacology has been kind to shikonin. Of the herbs the Shennong Bencao Jing called “blood-cooling, toxin-resolving, eruption-promoting,” it is one of the few whose 2000-year-old indications now read as a clean translation of the actual mechanisms.

Anti-inflammatory — NF-κB and MAPK Suppression

Shikonin and acetylshikonin inhibit the NF-κB signalling axis at multiple points, suppressing TNF-α-induced IκBα phosphorylation, blocking nuclear translocation of the p65 subunit, and downregulating downstream inflammatory genes including COX-2, iNOS, IL-1β and IL-6. They additionally suppress p38 MAPK and JNK phosphorylation in keratinocytes and macrophages.

In plain clinical translation: applied to inflamed, weeping, or erythematous skin, shikonin formulations measurably lower the local production of the cytokines that drive redness, swelling, and itch. This is the molecular spine of the Shennong Bencao Jing’s “clears heat, cools blood” classification — and the reason 21st-century papers describe Zi Cao as an evidence-based candidate for psoriasis, atopic dermatitis, and contact dermatitis topical management.

Wound Healing — Fibroblast Migration and EMT

Shikonin promotes the proliferation of dermal fibroblasts, stimulates collagen deposition in granulation tissue, and increases the migration of CD11b⁺ myeloid cells into the wound bed. A 2013 PLOS One study formally demonstrated that shikonin stimulates epithelial-mesenchymal transition (EMT) in keratinocytes, the cellular programme that lets a wound edge migrate across an open defect — i.e., it accelerates re-epithelialisation.

This is the mechanism behind the burn-dressing reputation: a partial-thickness burn dressed with a Zicao-oil-soaked gauze re-epithelialises faster than a saline-only dressing in the comparative clinical literature, and the wound bed shows lower expression of pro-inflammatory cytokines on histology.

Antimicrobial

Shikonin and its esters show measurable in vitro activity against Staphylococcus aureus (including some methicillin-resistant isolates), Streptococcus pyogenes, and certain dermatophytes — exactly the bacterial flora that opportunistically colonise burns, eczema fissures, and nappy-rash. The antimicrobial spectrum is modest by antibiotic standards but is directly complementary to the wound-healing and anti-inflammatory effects, which is why Zi Cao formulations historically out-performed plain oil dressings in pre-antibiotic-era burn care.

TLR2 / Innate-Immunity Modulation

Recent (post-2020) papers on Zi Cao and psoriasis specifically implicate shikonin’s downregulation of TLR2 expression on keratinocytes — a pathway directly relevant to the Streptococcus-triggered guttate psoriasis and to plaque-disease flare biology. The lesion-reducing effect of Lithospermum erythrorhizon topical preparations in psoriasis models maps mechanistically onto TLR2 + NF-κB + IL-17 axis suppression, which is the same axis that biologic drugs like secukinumab target by other means.

Anticancer Pharmacology — Why You See “Shikonin” Outside the Dermatology Literature

If you search PubMed for “shikonin” you will find that the majority of contemporary papers are oncology, not dermatology. Shikonin is a well-characterised inducer of pyroptosis and necroptosis in tumour cell lines and an inhibitor of pyruvate kinase M2 (PKM2), a tumour-metabolism enzyme. This is genuinely interesting biology and it has produced a handful of clinical-trial-stage shikonin-derivative anticancer candidates, but it is not the reason Zi Cao is in your medicated-oil cabinet. Topical shikonin at burn-dressing concentrations does not deliver systemically meaningful doses. The oncology pharmacology is a separate, IV-or-encapsulated-formulation story.

TCM Action — How the Classical Indications Map to the Chemistry

The Bencao description of Zi Cao is unusually consistent across the millennium:

The first three actions are external. The fourth is internal and is almost entirely historical — it survives in classical formulae but is rarely invoked in modern practice because (a) the active pigments are lipophilic and poorly absorbed from a water decoction, and (b) the PA hepatotoxicity concern, real for L. erythrorhizon, eliminates oral use as a routine option.

Why Zi Cao Is Almost Never Used Internally Anymore

Three converging reasons:

1. Pharmacokinetics. The naphthoquinone pigments are fat-soluble. A water decoction extracts little of them. The pharmacological action is concentrated in the lipid fraction, which is why every traditional preparation worth its weight is oil-based and topical.
2. PA hepatotoxicity. Lithospermum erythrorhizon — the historical source — carries pyrrolizidine alkaloids implicated in hepatic veno-occlusive disease. The 2020 Chinese Pharmacopoeia walked away from this species precisely because of this. Arnebia euchroma is lower-risk but is still not aggressively used orally.
3. Better-targeted oral alternatives exist. Modern TCM “cool the blood, resolve toxin” oral formulae lean on Sheng Di Huang, Mu Dan Pi, Chi Shao, and Lian Qiao — herbs with better oral bioavailability and no PA load. Zi Cao migrated to the topical cabinet not because it lost its reputation but because the topical compartment is where its chemistry actually works.

Use Inside Medicated Oils — What Zi Cao Brings to the Formula

In a contemporary medicated-oil context, Zi Cao is the anti-inflammatory, wound-friendly, blood-cooling pigment base that turns up specifically in:

• Burn ointments — Zicao Gao, Shiun-Kō, hospital-compounded Zi Cao You.
• Nappy-rash and napkin dermatitis oils — particularly Taiwanese apothecary-compounded formulae and Japanese kanpo paediatric preparations.
• Eczema and atopic-dermatitis topicals — both as the lead herb in Shiun-Kō and as a colour-and-anti-inflammatory adjunct in proprietary lines.
• Haemorrhoid and anal-fissure ointments — leveraging the same anti-inflammatory + wound-healing + mild-antimicrobial profile in a mucosal context (rectal mucosa is short-segment and the topical-only constraint still holds).
• Post-radiotherapy skin-care formulae — a relatively new application in integrative oncology clinics, where Zi Cao oil dressings are used for radiation dermatitis with reasonable supporting case-series evidence.

You will rarely see Zi Cao in a sports-injury or analgesic medicated oil — it does not deliver counter-irritation, it does not warm, it does not penetrate to deep tissues. Its compartment is the skin surface and the open wound, and inside that compartment it is one of the most pharmacologically well-supported herbs in the East Asian topical tradition.

Safety, Cautions, and Sourcing Notes

• External use only in modern practice unless a qualified TCM physician specifically prescribes an internal preparation; even then, oral courses should be short and PA-screened.
• Source matters. PRC-manufactured products should specify Arnebia euchroma or A. guttata. Japanese and Korean products may still legitimately use Lithospermum erythrorhizon; this is acceptable for topical use but not for internal use.
• Pregnancy. Topical Zi Cao oil is widely used in postpartum nipple-fissure and perineal-care preparations in Japan and Taiwan, but oral use during pregnancy is contraindicated due to the historical haemostasis-disrupting and PA-related cautions.
• Staining. Zi Cao oil stains cotton, linen, and ceramic tile permanently. Always dress wounds with disposable gauze over a barrier, not with patient clothing.
• Storage. The naphthoquinone pigments are mildly photolabile. Store finished Zi Cao oil and ointments in opaque glass or aluminium, away from direct sunlight, ideally below 25 °C. A well-made Zicao Gao in a sealed tin keeps its colour and activity for 18–24 months.

Bottom Line

Zi Cao is the rare TCM herb where the Shennong Bencao Jing’s 2000-year-old shorthand — “cools blood, resolves toxin, dispels macules, activates blood” — translates, almost line for line, into a 2026 mechanism slide: NF-κB and MAPK suppression in inflamed skin, TLR2 / IL-17 axis downregulation in plaque dermatoses, fibroblast and keratinocyte migration in open wounds, modest antibacterial activity against the staphylococci and streptococci that complicate burns and eczema, all delivered through a lipophilic naphthoquinone pigment family that only releases its colour and its activity into oil.

That is why every East Asian dispensary still has a jar of something burgundy on the shelf, and why the moment a burns gauze comes off a Chinese hospital trolley stained the colour of red wine you know exactly what was on it.